Cardiovascular Risk Assessment

Med Clin North Am. 2017 Jul;101(4):673-688. doi: 10.1016/j.mcna.2017.03.002.

Abstract

Cardiovascular risk assessment is fundamental to prevention of cardiovascular disease, because it helps determine the size of the potential benefits that might accrue to individual patients from use of statins, aspirin, and other preventive interventions. Current guidelines recommend specific algorithms for cardiovascular risk assessment that combine information from traditional risk factors including blood pressure, lipids, and smoking, along with age and sex and other factors. These algorithms are the subject of active research and controversy. This article addresses the rationale, current guidelines and use, and potential future directions of cardiovascular risk assessment.

Keywords: Biomarkers; Cardiovascular disease prevention; Cardiovascular risk; Risk factors; Risk prediction.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Ankle Brachial Index
  • Biomarkers
  • Blood Glucose
  • Blood Pressure
  • Body Mass Index
  • C-Reactive Protein / analysis
  • Calcium / analysis
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / prevention & control
  • Coronary Vessels / chemistry
  • Exercise
  • Genetic Predisposition to Disease
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Lipids / blood
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior
  • Sex Factors
  • Smoking / epidemiology
  • Socioeconomic Factors

Substances

  • Biomarkers
  • Blood Glucose
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids
  • C-Reactive Protein
  • Calcium